CN106908525B - A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance - Google Patents

A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance Download PDF

Info

Publication number
CN106908525B
CN106908525B CN201710027510.1A CN201710027510A CN106908525B CN 106908525 B CN106908525 B CN 106908525B CN 201710027510 A CN201710027510 A CN 201710027510A CN 106908525 B CN106908525 B CN 106908525B
Authority
CN
China
Prior art keywords
impurity
acetonitrile
analysis method
substance
acetate buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710027510.1A
Other languages
Chinese (zh)
Other versions
CN106908525A (en
Inventor
于梦
孙玲
王金虎
段崇刚
赵思太
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Freda Medical Group Co ltd
Shandong Academy of Pharmaceutical Sciences
Original Assignee
Shandong Freda Medical Group Co ltd
Shandong Academy of Pharmaceutical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Freda Medical Group Co ltd, Shandong Academy of Pharmaceutical Sciences filed Critical Shandong Freda Medical Group Co ltd
Priority to CN201710027510.1A priority Critical patent/CN106908525B/en
Publication of CN106908525A publication Critical patent/CN106908525A/en
Application granted granted Critical
Publication of CN106908525B publication Critical patent/CN106908525B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance, it is characterized in that using high performance liquid chromatography, gradient elution is carried out in the chromatographic column of acid seromucoid bonded silica gel using acetonitrile and acetate buffer as mobile phase with acetonitrile-water mixed solution sample dissolution.This method can effectively measure the related substance in SC 69124 intermediate and SC 69124, especially realize the separation of under same chromatographic condition SC 69124 intermediate, SC 69124 and its isomers, side reaction product, catabolite etc., more efficient within a short period of time separation and the related impurities for identifying SC 69124 intermediate and SC 69124 provide more reliable foundation for the quality control of SC 69124.

Description

A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance
Technical field
The invention belongs to Pharmaceutical Analysis technical field, it is related to the related of a kind of measurement SC 69124 intermediate and SC 69124 The analysis method of substance, especially with a kind of high performance liquid chromatography simultaneously to the isomery of SC 69124 intermediate and SC 69124 The method that body, side reaction product and catabolite are measured.
Background technique
SC 69124 intermediate 4- (5- methyl -3- phenyl -4- isoxazolyl) benzsulfamide (FD) and SC 69124 are Specific C OX-2 inhibitor, SC 69124 are the pro-drug of FD, and the two comes under the analgesia of the former times dry goods in anti-arthritic Medicine.Clinically SC 69124 is sold as the short medicine of postoperative pain in European market at present, after intermediate FD is because of listing Interests/Hazard ratio is unsatisfactory and withdraws from from American market.The two synthetic route is similar, it is contemplated that the risk of FD is established exclusive Strong, the sensitive reliable analysis method of property controls the related substance (being shown in Table 1) of FD and SC 69124, to the matter of SC 69124 Amount control is of great significance.
Summary of the invention
The object of the present invention is to provide a kind of measurement SC 69124 intermediate 4- (5- methyl -3- phenyl -4- isoxazolyls) The high-efficient liquid phase color of the isomers, side reaction product and the catabolite that are generated in benzsulfamide and SC 69124 synthesis route Spectral analysis method can be used for study on the synthesis and the control of production process quality of SC 69124.
To achieve the above object, the technical scheme is that
A kind of measurement SC 69124 intermediate (FD) is with SC 69124 in relation to the analysis method of substance, using high-efficient liquid phase color Spectrometry selects the chiral chromatographic column of acid seromucoid bonded silica gel, with acetonitrile-water mixed solution sample dissolution with acetonitrile-vinegar Phthalate buffer is that mobile phase carries out gradient elution.
The SC 69124 intermediate (FD) is 4- (5- methyl -3- phenyl -4- isoxazolyl) benzsulfamide, and the pa is auspicious Former times cloth is N- [[4- (5- methyl -3- phenyl -4- isoxazolyl) phenyl] sulfonyl] propionamide, and related substance is impurity A, impurity B, impurity C, impurity D, impurity E, impurity F and impurity G (being shown in Table 1).
1 SC 69124 of table, FD and its related structure of matter formula
The eluent gradient elution program is shown in Table 2.
2 eluent gradient elution program of table
In the method, analytical solution is made in the acetonitrile-water mixed solution sample dissolution for being 40:60 with volume ratio.
The chromatographic column is CHIRALPAK AGP, 4mm × 100mm, 5 μm.
The flowing phase composition is acetonitrile-ammonium acetate buffer, and wherein ammonium acetate buffer concentration is 0.01mol/L, pH 4.0。
Chromatographic condition includes: that Detection wavelength is 215nm;Mobile phase elution rate is 0.7mL/min;Chromatogram column temperature is 25 ℃;Sample injection volume is 10 μ L.
It is generated in SC 69124 synthesis route the beneficial effects of the present invention are: can effectively measure within a short period of time Isomers, side reaction product and degradation impurity, have saved the time, reduce testing cost, can be used for SC 69124 study on the synthesis It is controlled with the quality of production process, the quality of Related product is made to be guaranteed.
Detailed description of the invention
Reference substance liquid chromatogram after the deduction blank operation of Fig. 1 embodiment 1.
Reference substance liquid chromatogram after the deduction blank operation of Fig. 2 embodiment 2.
Test sample liquid chromatogram after the deduction blank operation of Fig. 3 embodiment 2.
In figure: 1- SC 69124;2-FD;3- impurity A;4- impurity B;5- impurity C;6- impurity D;7- impurity E;8- impurity F; 9- impurity G.
Specific embodiment
Technical solution of the present invention is further described below in conjunction with specific embodiment, the embodiment provided is only for illustrating this Invention, the range being not intended to be limiting of the invention.
This experimental evidence chromatographic column operation instructions are recommended, preferential that isopropanol system, acetonitrile system is selected to carry out investigation examination It tests.On the basis of considering the Detection wavelength of the durability that chromatographic column uses, measurement ingredient, determine to use acetonitrile system.In second Each chromatographic peak peak shape is poor after finding sample introduction after testing in nitrile system, and separating degree is bad, therefore considers that buffer salt is added, after test Preferably 0.01mol/L ammonium acetate solution.
Embodiment 1
(1) instrument and chromatographic condition
High performance liquid chromatograph: 1260 highly effective liquid phase chromatographic system of Agilent and work station.
Chromatographic column: acid seromucoid chromatographic column (CHIRALPAK AGP, 4mm × 100mm, 5 μm).
The ammonium acetate solution for preparing 0.01mol/L is water phase, acetonitrile-water phase in mobile phase with vinegar acid for adjusting pH value to 6.0 Ratio carries out gradient elution by table 3, and setting flow velocity is 0.6mL/min, and Detection wavelength 215nm, column temperature is 25 DEG C.
Table 3
(2) experimental procedure
Take SC 69124, FD, impurity A, B, C, D, E, F, G reference substance appropriate respectively, simultaneously with acetonitrile-water (40:60) dissolution The mixed solution containing SC 69124, FD, about 2 μ g of each impurity is made in every 1mL in dilution, as reference substance solution.Pa Rui is taken respectively Former times cloth sample, FD sample, impurity A, B, C, D, E, F, appropriate G, with method prepare in every 1mL containing about SC 69124, FD 0.5mg and The mixed solution of other each 2 μ g of impurity, as test solution.
(3) measuring method and result
It takes above-mentioned 10 μ L of solution by (1) chromatographic condition sample introduction, runs 46min, record chromatogram, investigate SC 69124, FD With the separating degree between each impurity, each impurity.The result shows that each impurity separating degree is good (see Fig. 1) in reference substance solution, but supply SC 69124 chromatographic peak is split point in test sample solution, and impurity is influenced when measuring related substance in SC 69124 and is separated with main peak Degree.Advanced optimize chromatographic condition such as embodiment 2.
Embodiment 2
(1) instrument and chromatographic condition
High performance liquid chromatograph: 1260 highly effective liquid phase chromatographic system of Agilent and work station.
Chromatographic column: acid seromucoid chromatographic column (CHIRALPAK AGP, 4mm × 100mm, 5 μm).
The ammonium acetate solution for preparing 0.01mol/L is water phase, acetonitrile-water phase in mobile phase with vinegar acid for adjusting pH value to 4.0 Ratio carries out gradient elution by table 4, and setting flow velocity is 0.7mL/min, and Detection wavelength 215nm, column temperature is 25 DEG C.
Table 4
(2) experimental procedure
Take SC 69124, FD, impurity A, B, C, D, E, F, G reference substance appropriate respectively, simultaneously with acetonitrile-water (40:60) dissolution The mixed solution containing SC 69124, FD, about 2 μ g of each impurity is made in every 1mL in dilution, as reference substance solution.Pa Rui is taken respectively Former times cloth sample, FD sample, impurity A, B, C, D, E, F, appropriate G, with method prepare in every 1mL containing about SC 69124, FD 0.5mg and The mixed solution of other each 2 μ g of impurity, as test solution.
(3) measuring method and result
Take above-mentioned 10 μ L of solution by (1) chromatographic condition sample introduction, run 42min, record chromatogram, investigate SC 69124, in Separating degree between mesosome, each impurity.The result shows that each impurity separating degree of reference substance solution is good (see Fig. 2), test solution In separating degree is good between each impurity and principal component, each ingredient chromatographic peak peak shape is good (see Fig. 3).

Claims (5)

1. a kind of analysis method of measurement SC 69124 intermediate FD with SC 69124 in relation to substance, characterized in that using efficient Liquid chromatography is selected the chiral chromatographic column of acid seromucoid bonded silica gel, is made with acetonitrile-water mixed solution sample dissolution Gradient elution is carried out with acetonitrile-acetic acid ammonium acetate buffer, acetic acid ammonium acetate buffer pH is 4.0, Detection wavelength 215nm;
The SC 69124 intermediate FD is 4- (5- methyl -3- phenyl -4- isoxazolyl) benzsulfamide, and the SC 69124 is N- [[4- (5- methyl -3- phenyl -4- isoxazolyl) phenyl] sulfonyl] propionamide, related substance is impurity A, impurity B, impurity C, impurity D, impurity E, impurity F and impurity G:
The eluent gradient elution program is:
2. in analysis method as described in claim 1, characterized in that the acetonitrile-water mixed solution for being 40:60 with volume ratio is molten Solve sample.
3. in analysis method as described in claim 1, characterized in that the chromatographic column be CHIRALPAKAGP, 4mm × 100mm, 5 μm.
4. in analysis method as described in claim 1, characterized in that the acetonitrile-acetic acid ammonium acetate buffer, wherein vinegar Sour ammonium acetate buffer concentration is 0.01mol/L, pH4.0.
5. in analysis method as described in claim 1, characterized in that chromatographic condition includes: that Detection wavelength is 215nm, flowing Phase elution rate is 0.7mL/min, and chromatogram column temperature is 25 DEG C, and sample injection volume is 10 μ L.
CN201710027510.1A 2017-01-16 2017-01-16 A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance Active CN106908525B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710027510.1A CN106908525B (en) 2017-01-16 2017-01-16 A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710027510.1A CN106908525B (en) 2017-01-16 2017-01-16 A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance

Publications (2)

Publication Number Publication Date
CN106908525A CN106908525A (en) 2017-06-30
CN106908525B true CN106908525B (en) 2019-07-23

Family

ID=59206469

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710027510.1A Active CN106908525B (en) 2017-01-16 2017-01-16 A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance

Country Status (1)

Country Link
CN (1) CN106908525B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108164521B (en) * 2018-03-02 2020-11-13 成都新恒创药业有限公司 Parecoxib sodium degradation impurity, and preparation method, detection method and application thereof
CN108828127A (en) * 2018-06-21 2018-11-16 上药东英(江苏)药业有限公司 Liquid-phase chromatography method in relation to substance in a kind of detection Parecoxib Sodium and synthetic intermediate
CN111089931A (en) * 2019-11-28 2020-05-01 上海秀新臣邦医药科技有限公司 Detection method of parecoxib sodium gene genotoxicity impurity
CN114441666B (en) * 2020-11-05 2024-02-27 成都百裕制药股份有限公司 Method for detecting impurities in 4- (5-methyl-3-phenyl-4-isoxazole) benzenesulfonyl chloride

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005065684A1 (en) * 2003-12-24 2005-07-21 Pharmacia Corporation Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever
CN104749288A (en) * 2015-04-16 2015-07-01 上海秀新臣邦医药科技有限公司 Liquid chromatographic analysis method for parecoxib-sodium related substances
CN104965041A (en) * 2015-06-11 2015-10-07 成都克莱蒙医药科技有限公司 High performance liquid chromatography detection method for parecoxib sodium isomer
CN105651927A (en) * 2014-11-14 2016-06-08 泰州复旦张江药业有限公司 An RT-HPLC detecting method for valdecoxib/parecoxib related substances

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005065684A1 (en) * 2003-12-24 2005-07-21 Pharmacia Corporation Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever
CN105651927A (en) * 2014-11-14 2016-06-08 泰州复旦张江药业有限公司 An RT-HPLC detecting method for valdecoxib/parecoxib related substances
CN104749288A (en) * 2015-04-16 2015-07-01 上海秀新臣邦医药科技有限公司 Liquid chromatographic analysis method for parecoxib-sodium related substances
CN104965041A (en) * 2015-06-11 2015-10-07 成都克莱蒙医药科技有限公司 High performance liquid chromatography detection method for parecoxib sodium isomer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Pharmacokinetics of intravenous and intramuscular parecoxib in healthy Beagles;M. Giorgi等;《The Veterinary Journal》;20121231;第193卷;246-250 *
基于高效液相色谱法的帕瑞昔布钠位置异构体测定;聂忠莉等;《成都大学学报(自然科学版)》;20160630;第35卷(第2期);113-115,119 *

Also Published As

Publication number Publication date
CN106908525A (en) 2017-06-30

Similar Documents

Publication Publication Date Title
CN106908525B (en) A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance
CN104965041B (en) A kind of high-efficiency liquid chromatography method for detecting of Parecoxib Sodium isomer
CN105784901A (en) High-sensitivity analysis method for gene impurity of imatinib
WO2016090730A1 (en) Method for determining content of impurities in lapatinib by using lc-ms/ms
CN104749288B (en) A kind of liquid phase chromatography analytical method of Parecoxib Sodium about material
CN109470799A (en) The purity and impurity position finding and detection method of Fmoc-Arg (Pbf)-OH
CN109900820A (en) A kind of method that HPLCMS-MS combination detects Quetiapine in human plasma
CN109342638A (en) A method of detecting nitrile, quaternary ammonium salt and its impurity ammonium, potassium, calcium ion content in blocking using cation exchange inhibition conductance method
CN101701942A (en) Method for separating and measuring entecavir and optical isomer thereof by liquid chromatography
CN107037150A (en) It is a kind of at the same determine food in Determination of Preservatives, sweetener and colouring agent method
CN105866315B (en) The assay method of amino acid in a kind of tobacco juice for electronic smoke
CN108732288A (en) A kind of tranexamic acid or its detection method in relation to content of material
CN110057959A (en) A kind of analysis method of the high effective liquid chromatography for measuring Febustat intermediate in relation to substance
CN105092720A (en) Method for measuring genotoxic impurities in pradaxa
CN111380993B (en) Method for analyzing related substances of roxasistat
CN114324703B (en) Method for simultaneously detecting multiple amino acids
CN109307716A (en) It is a kind of according to a detection method of the piperazine azoles in relation to substance
CN108693272B (en) Method for analyzing and preparing N- (p-toluenesulfonyl) -L-alanine and enantiomer thereof by HPLC method
CN107525877A (en) A kind of method using liquid chromatography for separating and determining according to a piperazine azoles and its impurity
CN103389347A (en) Method for measuring Doripenem and/or relevant substances by utilizing high performance liquid chromatography
CN104458992A (en) Monitoring method of in-process residual impurities of gibenclamide hypoglycemic drug
CN107490631A (en) A kind of analyzing detecting method of afatinib intermediate
CN107490630B (en) Analytical detection method of 7-fluoro-4-hydroxyquinazoline
CN110988200A (en) Analysis method of imidazole residue in recombinant human teriparatide for injection
CN108918692A (en) A kind of method of separating and assaying of L-2- amino-butanamide hydrochloride and its isomers

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 250101 989 Xinjie street, Ji'nan high tech Zone, Shandong

Applicant after: Pharmaceutical Sciences, Shandong Province

Applicant after: Shandong Freda Pharmaceutical Group Co., Ltd.

Address before: 250101 989 Xinjie street, Ji'nan high tech Zone, Shandong

Applicant before: Pharmaceutical Sciences, Shandong Province

Applicant before: Shandong Fu Ruida Pharmaceutical Group company

GR01 Patent grant
GR01 Patent grant